Citigroup’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-44
| Closed | -$6K | – | 5751 |
|
|
2021
Q1 | $6K | Sell |
44
-83
| -65% | -$11.3K | ﹤0.01% | 5201 |
|
|
2020
Q4 | $20K | Buy |
127
+92
| +263% | +$14.5K | ﹤0.01% | 4633 |
|
|
2020
Q3 | $3K | Sell |
35
-96
| -73% | -$8.23K | ﹤0.01% | 4879 |
|
|
2020
Q2 | $15K | Sell |
131
-95
| -42% | -$10.9K | ﹤0.01% | 4450 |
|
|
2020
Q1 | $17K | Buy |
226
+56
| +33% | +$4.21K | ﹤0.01% | 4448 |
|
|
2019
Q4 | $50K | Sell |
170
-67
| -28% | -$19.7K | ﹤0.01% | 3968 |
|
|
2019
Q3 | $43K | Buy |
237
+42
| +22% | +$7.62K | ﹤0.01% | 3843 |
|
|
2019
Q2 | $78K | Buy |
195
+20
| +11% | +$8K | ﹤0.01% | 3792 |
|
|
2019
Q1 | $82K | Sell |
175
-11
| -6% | -$5.15K | ﹤0.01% | 3715 |
|
|
2018
Q4 | $89K | Buy |
186
+32
| +21% | +$15.3K | ﹤0.01% | 3563 |
|
|
2018
Q3 | $105K | Buy |
154
+77
| +100% | +$52.5K | ﹤0.01% | 3554 |
|
|
2018
Q2 | $53K | Buy |
+77
| New | +$53K | ﹤0.01% | 3833 |
|